Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
ABMD
Abiomed Inc
ABMD
|
$296M |
| 2 |
Illumina
ILMN
|
$294M |
| 3 |
Trade Desk
TTD
|
$281M |
| 4 |
Axon Enterprise
AXON
|
$248M |
| 5 |
Broadridge
BR
|
$244M |
Top Sells
| 1 |
Verisk Analytics
VRSK
|
$512M |
| 2 |
FRC
First Republic Bank
FRC
|
$323M |
| 3 |
Baidu
BIDU
|
$312M |
| 4 |
ICICI Bank
IBN
|
$234M |
| 5 |
Stellantis
STLA
|
$200M |
Sector Composition
| 1 | Consumer Discretionary | 32.32% |
| 2 | Healthcare | 17.27% |
| 3 | Communication Services | 16.52% |
| 4 | Financials | 10.83% |
| 5 | Technology | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Infosys
INFY
$69.7B
| $14M | 0.01% | 1,304,732 +68,860 | +6% | +$737K |
|
177
Exelon
EXC
$44.1B
| $13.5M | 0.01% | 282,630 -265,126 | -48% | -$12.7M |
|
178
Adicet Bio
ACET
$59.9M
| $13M | 0.01% | 1,271,387 | – | – |
|
|
ORTX
179
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $12.9M | 0.01% | 925,000 | – | – |
|
180
Ecolab
ECL
$78.6B
| $12.7M | 0.01% | 64,382 +11,453 | +22% | +$2.26M |
|
|
ONC
181
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $12.2M | 0.01% | 98,524 +2,950 | +3% | +$366K |
|
|
182
Verisk Analytics
VRSK
$37.5B
| $11.6M | 0.01% | 79,376 -3,496,189 | -98% | -$512M |
|
183
MRC Global
MRC
$1.28B
| $11.1M | 0.01% | 650,000 | – | – |
|
184
Veeco
VECO
$1.48B
| $10.5M | 0.01% | 859,481 -775,312 | -47% | -$9.47M |
|
185
CEVA Inc
CEVA
$531M
| $10.1M | 0.01% | 415,727 -2,039 | -0.5% | -$49.6K |
|
186
BlackRock Floating Rate Income Trust
BGT
$319M
| $9.96M | 0.01% | 802,170 | – | – |
|
|
VAR
187
DELISTED
Varian Medical Systems, Inc.
VAR
| $9.86M | 0.01% | 72,439 -36,465 | -33% | -$4.96M |
|
|
FTCH
188
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $9.62M | 0.01% | +462,330 | New | +$9.62M |
|
189
Sherwin-Williams
SHW
$91.2B
| $8.98M | 0.01% | 19,584 | – | – |
|
|
LN
190
DELISTED
LINE Corporation
LN
| $8.7M | 0.01% | 309,160 +1,563 | +0.5% | +$44K |
|
|
NCNA
191
NuCana
NCNA
$6.09M
| $8.59M | 0.01% | 827,308 | – | – |
|
192
Evolent Health
EVH
$1.12B
| $8.53M | 0.01% | 1,072,417 -967 | -0.1% | -$7.69K |
|
193
British American Tobacco
BTI
$124B
| $7.32M | 0.01% | 209,808 +2,824 | +1% | +$98.5K |
|
|
KDNY
194
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $6.27M | 0.01% | 4,070,724 +239,298 | +6% | +$369K |
|
|
PHD
195
Pioneer Floating Rate Fund
PHD
$123M
| $5.89M | 0.01% | 550,936 | – | – |
|
|
SINA
196
DELISTED
Sina Corp
SINA
| $5.67M | 0.01% | 131,550 | – | – |
|
|
KLDO
197
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $5.1M | 0.01% | 440,000 | – | – |
|
198
HUTCHMED
HCM
$2.58B
| $4.79M | 0.01% | 217,911 -2,985 | -1% | -$65.7K |
|
199
Rio Tinto
RIO
$102B
| $4.4M | ﹤0.01% | 70,626 | – | – |
|
200
Schlumberger
SLB
$55B
| $4.39M | ﹤0.01% | 110,529 | – | – |
|